Delcath Systems (DCTH) Metrics: History & Chart

Delcath Systems, Inc.(DCTH)

Medical - Devices · Queensbury, NY

$15.53-0.34 (-2.14%)

Delayed quote: Oct 6, 2026, 10:15 AM EDT

About Delcath Systems, Inc.

Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investigational product is the HEPZATO KIT, a unique hepatic delivery system for melphalan that targets high-dose chemotherapy specifically to the liver. This innovative approach aims to substantially reduce systemic drug exposure and mitigate associated side effects. HEPZATO's clinical evaluation is advancing through the FOCUS trial, which is designed to assess the objective response rate in individuals with metastatic uveal melanoma whose disease is primarily concentrated in the liver. Furthermore, the company offers a separate version of HEPZATO as a medical device in Europe, marketed under the CHEMOSAT Hepatic Delivery System brand (or simply CHEMOSAT). This system empowers European medical centers to manage a diverse array of liver cancer conditions. Delcath Systems, Inc. was established in 1988, with its corporate headquarters situated in New York, New York.

Queensbury, NY

156 employees

www.delcath.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Gerard J. Michel

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+0.38%
30D Total Return	-3.70%
YTD Total Return	+57.13%
1Y Total Return	+42.97%
3Y Total Return	+336.02%
5Y Total Return	+67.74%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+57.13%
2025	-16.11%
2024	+189.42%
2023	+15.56%
2022	-53.55%
2021	-56.75%
2020

CAGR TTM	+42.73%
CAGR 3Y	+63.35%
CAGR 5Y	+10.90%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	1220.77
PE Ratio Avg TTM	806.49
PE Ratio Avg 3Y	715.80
Current VS TTM Avg	+51.37%
Current VS 3Y Avg	+70.55%
Current VS 5Y Avg	+70.55%

All Metrics

DCTH Valuation Metrics

DCTH Stock Price Metrics

DCTH Dividend Metrics

DCTH Growth Rate Metrics

DCTH Discounted Cash Flow Metrics

DCTH Returns By Period

DCTH Yearly Returns

DCTH Average Annual Returns By Period (CAGR)

DCTH Revenue Metrics

DCTH PE Ratio Metrics

DCTH PS Ratio Metrics

DCTH PB Ratio Metrics

DCTH Price to Free Cash Flow Ratio Metrics

DCTH Debt to Equity Ratio Metrics

DCTH PEG Ratio Metrics

DCTH FCF Yield

DCTH Earnings Yield

DCTH EBITDA Yield

DCTH OCF Yield

DCTH EV/EBIT Ratio Metrics

DCTH EV/EBITDA Ratio Metrics

DCTH EV/Assets Ratio Metrics

DCTH EV/Sales Ratio Metrics

DCTH Current Ratio Metrics

DCTH Quick Ratio Metrics

DCTH ROIC Metrics

DCTH Return on Assets Metrics

DCTH Return on Equity Metrics

DCTH Net Profit Margin Metrics

DCTH Gross Profit Margin Metrics

DCTH Tax Rate Metrics

PS Ratio	6.61
PS Ratio Avg TTM	5.00
PS Ratio Avg 3Y	15.94
Current VS TTM Avg	+32.27%
Current VS 3Y Avg	-58.54%
Current VS 5Y Avg	-60.21%

PB Ratio	5.21
PB Ratio Avg TTM	3.66
PB Ratio Avg 3Y	5.28
Current VS TTM Avg	+42.35%
Current VS 3Y Avg	-1.31%
Current VS 5Y Avg	+4.03%

PFCF Ratio	36.04
PFCF Ratio Avg TTM	27.66
PFCF Ratio Avg 3Y	27.66
Current VS TTM Avg	+30.29%
Current VS 3Y Avg	+30.29%
Current VS 5Y Avg	+30.29%

Debt/Equity Ratio	0.02
Debt/Equity Ratio Avg TTM	0.01
Debt/Equity Ratio Avg 3Y	0.19
Current VS TTM Avg	+85.99%
Current VS 3Y Avg	-89.20%
Current VS 5Y Avg	-94.17%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.77%
FCF Yield Avg TTM	3.62%
FCF Yield Avg 3Y	3.23%
Current VS TTM Avg	-23.42%
Current VS 3Y Avg	-14.32%
Current VS 5Y Avg	-14.32%

Earnings Yield	0.08%
Earnings Yield Avg TTM	0.28%
Earnings Yield Avg 3Y	0.25%
Current VS TTM Avg	-71.45%
Current VS 3Y Avg	-67.41%
Current VS 5Y Avg	-67.41%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	614.19
Ev/Ebit Ratio Avg TTM	189.50
Ev/Ebit Ratio Avg 3Y	189.50
Current VS TTM Avg	+224.11%
Current VS 3Y Avg	+224.11%
Current VS 5Y Avg	+224.11%

Ev/Ebitda Ratio	424.47
Ev/Ebitda Ratio Avg TTM	144.36
Ev/Ebitda Ratio Avg 3Y	144.36
Current VS TTM Avg	+194.04%
Current VS 3Y Avg	+194.04%
Current VS 5Y Avg	+194.04%

Ev/Assets Ratio	4.28
Ev/Assets Ratio Avg TTM	3.07
Ev/Assets Ratio Avg 3Y	3.84
Current VS TTM Avg	+39.54%
Current VS 3Y Avg	+11.33%
Current VS 5Y Avg	+50.32%

Ev/Sales Ratio	6.14
Ev/Sales Ratio Avg TTM	4.51
Ev/Sales Ratio Avg 3Y	13.15
Current VS TTM Avg	+36.09%
Current VS 3Y Avg	-53.32%
Current VS 5Y Avg	-56.75%

Current Ratio	9.83
Current Ratio Avg TTM	11.58
Current Ratio Avg 3Y	7.66
Current VS TTM Avg	-15.14%
Current VS 3Y Avg	+28.30%
Current VS 5Y Avg	+66.63%

Quick Ratio	8.95
Quick Ratio Avg TTM	10.57
Quick Ratio Avg 3Y	6.95
Current VS TTM Avg	-15.32%
Current VS 3Y Avg	+28.78%
Current VS 5Y Avg	+66.15%

ROIC	(0.81%)
ROIC Avg 3Y	(72.81%)
ROIC Avg 5Y	(111.65%)
Current VS 3Y Avg	+98.89%
Current VS 5Y Avg	+99.28%
Current VS 10Y Avg	+99.36%

ROA	0.39%
ROA Avg TTM	0.51%
ROA Avg 3Y	(13.22%)
Current VS TTM Avg	-22.98%
Current VS 3Y Avg	+102.95%
Current VS 5Y Avg	+101.84%

ROE	0.44%
ROE Avg TTM	1.31%
ROE Avg 3Y	(116.30%)
Current VS TTM Avg	-66.33%
Current VS 3Y Avg	+100.38%
Current VS 5Y Avg	+100.27%

Net Profit Margin	0.56%
Net Profit Margin Avg TTM	2.19%
Net Profit Margin Avg 3Y	(52.04%)
Current VS TTM Avg	-74.39%
Current VS 3Y Avg	+101.08%
Current VS 5Y Avg	+100.08%

Gross Profit Margin	87.05%
Gross Pft Margin Avg TTM	86.76%
Gross Pft Margin Avg 3Y	80.75%
Current VS TTM Avg	+0.34%
Current VS 3Y Avg	+7.81%
Current VS 5Y Avg	+11.62%

Tax Rate	15.54%
Tax Rate Avg 3Y	(14.90%)
Tax Rate Avg 5Y	(14.90%)
Current VS 3Y Avg	+204.30%
Current VS 5Y Avg	+204.30%
Current VS 10Y Avg	+245.93%